Carvajal, Richard D.
Sacco, Joseph J. http://orcid.org/0000-0003-2591-9796
Jager, Martine J. http://orcid.org/0000-0003-2261-3820
Eschelman, David J.
Olofsson Bagge, Roger http://orcid.org/0000-0001-5795-0355
Harbour, J. William
Chieng, Nicholas D. http://orcid.org/0000-0003-1960-8123
Patel, Sapna P.
Joshua, Anthony M. http://orcid.org/0000-0001-5159-4580
Piperno-Neumann, Sophie
Article History
Accepted: 16 November 2022
First Online: 4 January 2023
Competing interests
: R.D.C. has acted as a consultant for Alkermes, Aura Biosciences, Bristol Myers Squibb, Castle Biosciences, Chimeron, Delcath, Eisai, Hengrui, Ideaya, Immunocore, InxMed, Iovance, Merck, Novartis, Oncosec, Pierre Fabre, PureTech Health, Regeneron, Rgenix, Sanofi Genzyme, Sorrento Therapeutics and TriSalus Life Sciences; holds stock options in Aura Biosciences, Chimeron and Rgenix; and has received research funding through his institution from Amgen, Astellis, AstraZeneca, BioMed Valley, Bolt, Bristol Myers Squibb, Corvus, Cstone, Foghorn, Ideaya, Immatics, Immunocore, InxMed, Iovance, Merck, Mirati, Novartis, Pfizer, Plexxikon, Regeneron and Roche/Genentech. J.J.S. has acted as a consultant for Bristol Myers Squibb, Delcath, Immunocore and Merck Sharp & Dohme; has received speaker’s honoraria from Pierre-Fabre and Immunocore; and research funding through his institution from AstraZeneca, Bristol Myers Squibb, Immunocore, Merck Sharp & Dohme and Replimune. D.J.E. has acted as a consultant for Delcath. R.O.B. has acted as a consultant for Amgen, BD/BARD, Bristol Myers Squibb, Merck Sharp & Dohme, Novartis, Roche and Sanofi Genzyme; has received speaker’s honoraria from Pfizer and Roche; is a shareholder of SATMEG Ventures AB; and has received research funding through his institution from Bristol Myers Squibb and SkyLineDx. J.W.H. has acted as a consultant for Castle Biosciences and Immunocore; and receives patent royalties from Washington University. S.P.P. has acted as a consultant for Advance Knowledge in Healthcare, Bristol Myers Squibb, Cardinal Health, Delcath, Immunocore, Novartis and TriSalus Life Sciences; and has received research funding through her institution from Bristol Myers Squibb, Foghorn Therapeutics, Ideaya, InxMed, Lvgen, Novartis, Provectus Biopharmaceuticals, Seagen, Syntrix Bio and TriSalus Life Sciences. A.M.J. has received research funding through his institution from Ideaya and Immunocore. M.J.J., N.D.C. and S.P.-N. declare no competing interests.